Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
Ocular Therapeutix, Inc. (OCUL)
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ocutx.com
Company Research
Source: GlobeNewswire
First quarter 2024 financial results to be reported on Tuesday, May 7, 2024 Investor Day to replace first quarter 2024 earnings conference call; quarterly calls to resume regular cadence with second quarter 2024 financial results BEDFORD, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, announced plans to report first quarter 2024 financial results on Tuesday, May 7, 2024, after 4:00 p.m. Eastern Time. The Company plans to host an Investor Day in New York City on Thursday, June 13, 2024, in lieu of a first quarter 2024 earnings conference call. Quarterly earnings conference calls are expected to resume with the second quarter 2024 financial results.
Show less
Read more
Impact Snapshot
Event Time:
OCUL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCUL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCUL alerts
High impacting Ocular Therapeutix, Inc. news events
Weekly update
A roundup of the hottest topics
OCUL
News
- Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target lowered by analysts at HC Wainwright from $16.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target lowered by analysts at JMP Securities from $24.00 to $22.00. They now have a "market outperform" rating on the stock.MarketBeat
- Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target lowered by analysts at TD Cowen from $11.00 to $7.00. They now have a "hold" rating on the stock.MarketBeat
- Ocular Therapeutix™ Reports First Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- Ocular Therapeutix™ Reports First Quarter 2024 ResultsGlobeNewswire
OCUL
Earnings
- 3/11/24 - Miss
OCUL
Sec Filings
- 5/7/24 - Form S-8
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- OCUL's page on the SEC website